ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.460
+0.120 (8.96%)
At close: Mar 9, 2026, 4:00 PM EDT
1.480
+0.020 (1.37%)
After-hours: Mar 9, 2026, 5:35 PM EDT
ABVC BioPharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 0.68 | 0.25 | 0.06 | 0.09 | 5.83 | Upgrade
|
| Short-Term Investments | 0.06 | 0.06 | 0.08 | 0.08 | 0.11 | Upgrade
|
| Cash & Short-Term Investments | 0.75 | 0.31 | 0.14 | 0.16 | 5.94 | Upgrade
|
| Cash Growth | 138.20% | 124.51% | -13.41% | -97.29% | 38.93% | Upgrade
|
| Accounts Receivable | - | - | 0.01 | 0.86 | 0.43 | Upgrade
|
| Other Receivables | 0.76 | - | - | - | - | Upgrade
|
| Receivables | 0.76 | 1.16 | 0.76 | 1.37 | 0.43 | Upgrade
|
| Inventory | - | - | - | - | 0.03 | Upgrade
|
| Prepaid Expenses | 0.35 | 0.1 | 0.1 | 0.15 | 0.53 | Upgrade
|
| Restricted Cash | 0.65 | 0.62 | 0.66 | 1.31 | 0.74 | Upgrade
|
| Total Current Assets | 2.5 | 2.18 | 1.66 | 2.99 | 7.65 | Upgrade
|
| Property, Plant & Equipment | 14.75 | 1.15 | 1.38 | 1.74 | 2 | Upgrade
|
| Long-Term Investments | 1.88 | 2.26 | 2.53 | 0.84 | 0.93 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | 0.12 | 0.98 | Upgrade
|
| Other Long-Term Assets | 1.93 | 1.95 | 2.22 | 3.15 | 1.59 | Upgrade
|
| Total Assets | 21.06 | 7.54 | 7.78 | 9.58 | 13.7 | Upgrade
|
| Accrued Expenses | 4.16 | 3.21 | 3.12 | 2.44 | 1.3 | Upgrade
|
| Short-Term Debt | 0.76 | 1.46 | 0.92 | 1.91 | 1.87 | Upgrade
|
| Current Portion of Long-Term Debt | 0.8 | 1.09 | 1.04 | 0.34 | - | Upgrade
|
| Current Portion of Leases | 0.32 | 0.4 | 0.4 | 0.37 | 0.35 | Upgrade
|
| Current Income Taxes Payable | 0.01 | - | 0.11 | - | - | Upgrade
|
| Current Unearned Revenue | 0.01 | 0.08 | 0.08 | 0.01 | 0.01 | Upgrade
|
| Other Current Liabilities | 0.11 | 0.31 | 0.43 | 0.47 | 0.17 | Upgrade
|
| Total Current Liabilities | 6.16 | 6.56 | 6.1 | 5.54 | 3.69 | Upgrade
|
| Long-Term Leases | 1.6 | 0.24 | 0.41 | 0.79 | 1.12 | Upgrade
|
| Other Long-Term Liabilities | - | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
| Total Liabilities | 7.76 | 6.82 | 6.53 | 6.34 | 4.83 | Upgrade
|
| Common Stock | 0.03 | 0.01 | 0.01 | 0 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 96.01 | 78.6 | 73.98 | 67.94 | 58.11 | Upgrade
|
| Retained Earnings | -76.86 | -68.95 | -64.05 | -54.9 | -38.48 | Upgrade
|
| Treasury Stock | -8.91 | -8.91 | -8.9 | -9.1 | -9.1 | Upgrade
|
| Comprehensive Income & Other | 0.85 | 0.48 | 0.52 | -0.84 | -1.72 | Upgrade
|
| Total Common Equity | 11.11 | 1.23 | 1.55 | 3.1 | 8.84 | Upgrade
|
| Minority Interest | 2.19 | -0.5 | -0.3 | 0.14 | 0.03 | Upgrade
|
| Shareholders' Equity | 13.3 | 0.72 | 1.25 | 3.24 | 8.87 | Upgrade
|
| Total Liabilities & Equity | 21.06 | 7.54 | 7.78 | 9.58 | 13.7 | Upgrade
|
| Total Debt | 3.47 | 3.2 | 2.77 | 3.41 | 3.34 | Upgrade
|
| Net Cash (Debt) | -2.73 | -2.88 | -2.63 | -3.25 | 2.6 | Upgrade
|
| Net Cash Per Share | -0.14 | -0.25 | -0.61 | -1.03 | 1.04 | Upgrade
|
| Filing Date Shares Outstanding | 25.44 | 15.05 | 10.53 | 3.28 | 3 | Upgrade
|
| Total Common Shares Outstanding | 25.05 | 13.14 | 7.91 | 3.26 | 2.87 | Upgrade
|
| Working Capital | -3.66 | -4.38 | -4.45 | -2.56 | 3.96 | Upgrade
|
| Book Value Per Share | 0.44 | 0.09 | 0.20 | 0.95 | 3.09 | Upgrade
|
| Tangible Book Value | 11.11 | 1.23 | 1.55 | 3.1 | 8.84 | Upgrade
|
| Tangible Book Value Per Share | 0.44 | 0.09 | 0.20 | 0.95 | 3.09 | Upgrade
|
| Land | - | 0.34 | 0.36 | 0.36 | 0.4 | Upgrade
|
| Buildings | - | 2.22 | 2.23 | 2.23 | 2.24 | Upgrade
|
| Machinery | - | 1.29 | 1.31 | 1.29 | 1.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.